Exosome mimetics: a novel class of drug delivery systems

被引:431
|
作者
Kooijmans, Sander A. A. [1 ]
Vader, Pieter [1 ]
van Dommelen, Susan M. [1 ]
van Solinge, Wouter W. [1 ]
Schiffelers, Raymond M. [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, Utrecht, Netherlands
来源
基金
欧洲研究理事会;
关键词
exosomes; extracellular vesicles; liposomes; drug delivery systems; CELL-DERIVED EXOSOMES; DENDRITIC CELLS; PROTEOMIC ANALYSIS; MEMBRANE-VESICLES; TETRASPANINS CD9; FREE EXPRESSION; STEM-CELLS; IN-VIVO; CIRCULATING MICRORNAS; APOPTOTIC BODIES;
D O I
10.2147/IJN.S29661
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
The identification of extracellular phospholipid vesicles as conveyors of cellular information has created excitement in the field of drug delivery. Biological therapeutics, including short interfering RNA and recombinant proteins, are prone to degradation, have limited ability to cross biological membranes, and may elicit immune responses. Therefore, delivery systems for such drugs are under intensive investigation. Exploiting extracellular vesicles as carriers for biological therapeutics is a promising strategy to overcome these issues and to achieve efficient delivery to the cytosol of target cells. Exosomes are a well studied class of extracellular vesicles known to carry proteins and nucleic acids, making them especially suitable for such strategies. However, the considerable complexity and the related high chance of off-target effects of these carriers are major barriers for translation to the clinic. Given that it is well possible that not all components of exosomes are required for their proper functioning, an alternative strategy would be to mimic these vesicles synthetically. By assembly of liposomes harboring only crucial components of natural exosomes, functional exosome mimetics may be created. The low complexity and use of well characterized components strongly increase the pharmaceutical acceptability of such systems. However, exosomal components that would be required for the assembly of functional exosome mimetics remain to be identified. This review provides insights into the composition and functional properties of exosomes, and focuses on components which could be used to enhance the drug delivery properties of exosome mimetics.
引用
收藏
页码:1525 / 1541
页数:17
相关论文
共 50 条
  • [41] Novel Drug Delivery Systems for the Treatment of Glaucoma
    Cara E. Capitena Young
    Malik Y. Kahook
    Leonard K. Seibold
    Current Ophthalmology Reports, 2019, 7 : 143 - 149
  • [42] Biomaterials, novel drug and cell delivery systems
    Langer, Robert
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [43] Novel drug delivery systems for steroidal hormones
    Lipp, R
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2001, 11 (08) : 1291 - 1299
  • [44] Novel drug delivery systems for the treatment of glaucoma
    Vanrell, Rocio Herrero
    ACTA OPHTHALMOLOGICA, 2022, 100
  • [45] NOVEL DRUG DELIVERY SYSTEMS - CHIEN,YW
    SIVERLY, JR
    AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION, 1983, 47 (02) : 190 - 190
  • [46] NOVEL DRUG-DELIVERY SYSTEMS FOR HYPERTENSION
    PRISANT, LM
    BOTTINI, B
    DIPIRO, JT
    CARR, AA
    AMERICAN JOURNAL OF MEDICINE, 1992, 93 : S45 - S55
  • [47] Cyclodextrin based novel drug delivery systems
    Vyas, Amber
    Saraf, Shailendra
    Saraf, Swarnlata
    JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY, 2008, 62 (1-2) : 23 - 42
  • [48] Nanocapsules: The Weapons for Novel Drug Delivery Systems
    Kothamasu, Pavankumar
    Kanumur, Hemanth
    Ravur, Niranjan
    Maddu, Chiranjeevi
    Parasuramrajam, Radhika
    Thangavel, Sivakumar
    BIOIMPACTS, 2012, 2 (02) : 71 - 81
  • [49] BIONANOTECHNOLOGY AND NOVEL TARGETED DRUG DELIVERY SYSTEMS
    Syed, Atif
    ANTICANCER RESEARCH, 2014, 34 (10) : 6192 - 6192
  • [50] Polymers as novel drug delivery systems.
    Uhrich, KE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U292 - U292